Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Presented for research literature review only Cha YS (2008)
Retatrutide is currently being studied as a once-weekly subcutaneous injection, a route that allows the drug to be absorbed gradually and reliably into systemic circulation
Glucagon-receptor activation is being studied for its role in energy expenditure, hepatic metabolism and body-weight regulation , making Retatrutide mechanistically broader than both Semaglutide and Tirzepatide
In clinical trials, GLP-1 therapies have been shown to 14: Reduce HbA1C (a snapshot of blood sugar over three months) Support weight loss Improve overall metabolic control They are often used when first-line treatments like metformin are not enough, or when weight loss and cardiometabolic risk are key considerations
Most people notice better skin texture and hydration within a few weeks
